Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Stability claims for the access total t4 calibrators for calibrator lots 917074 and 008534 may not be met leading to delay in diagnosis of recurrence of thyroid cancer incorrect therapeutic dose of thyroid hormone supplementation in pregnancy or delay in diagnosis and/or treatment of hyperthyroidism or hypothyroidism. continued and/or emerging symptoms will likely prompt repeat testing but pediatric or pregnancy associated disease may be irreversible.